Back to search
Potentially Resectable Stage II/IIIa NSCLC
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Potentially Resectable Stage II/IIIa NSCLC trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Potentially Resectable Stage II/IIIa NSCLC trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Combination treatment of Durvalumab with chemoradiotherapy is ongoing for head/neck cancer, renal cell carcinoma, melanoma, and non-small cell lung cancer (NCT0…
This study is a single-arm prospective single-center phase II study. Subjects are untreated resectable II-IIIIA or potentially resectable T3-4N2 stage IIIB NSCL…
This is an open-label, randomised, two-arm, phase II, multi-centre clinical trial. 90 patients will be enrolled in this trial to examine the pathological Compl…
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-ray…